Nutrition

Latest News



A U.S. Food and Drug Administration (FDA) investigation of more than 1,000 retail markets which may have brought Chinese infant formula into the U.S. yielded no such items, the FDA stated.

The Food and Drug Administration (FDA) advised consumers not to purchase baby formula from China, in light of a recent Chinese infant death, reported Reuters.

A mother's diet around the time of conception may play a role in determining the gender of her baby, findings published April 22 in the online Proceedings of the Royal Society B: Biological Sciences suggest.

Infant formula enriched with extra proteins, fat, and nicronutrients like calcium and copper increased preterm infants' cognitive abilities. The study was published in Pediatric Research...

Estimates are that 40% to 60% of adolescents use nutritional supplements for a variety of reasons. According to Cora Collette Breuner, MD, MPH, FAAP, associate professor of pediatrics, University of Washington in Seattle, billions of dollars are spent each year by adolescents on these substances, who may hope to improve athletic performance, alleviate fatigue, improve appearance, and gain or lose weight.

Early attention to maternal diet and infant nutrition may help prevent allergy and food intolerance in high-risk infants who are unable to be completely breastfed, according to recent data and speakers at a dinner symposium Sunday evening. Speakers Peyton Eggleston, MD, professor of pediatrics at Johns Hopkins University School of Medicine; Mark Boguniewicz, MD, National Jewish Medical and Research Center and University of Colorado School of Medicine; and John A. Kerner, MD, Stanford University School of Medicine, discussed the rising prevalence of allergic disease worldwide and the key factors shaping the trend, the progression of atopic disease in genetically predisposed children, the factors associated with risk of developing allergic disease, and the evidence for a role of diet in preventing allergic disease in young children.

The US Food and Drug Administration (FDA) recently approved Adderall XR (an extended-release formulation of mixed salts of amphetamine) as a once-daily treatment for attention deficit hyperactivity disorder in adolescents 13 to 17 years old. That action bridges an "indication gap" between earlier approval of the product for patients 6 to 12 years old and for older (18 years) adolescents and adults.